Jim Cramer Likes Seneca Foods (SENEA) But is Hoping For a Pullback
Jim Cramer sees Seneca Foods Corporation (NASDAQ:SENEA) as an attractive food stock after its sharp rally, but he wants investors to leave room for a further pullback.
Insider Monkey Blog
Biogen (BIIB) and AbbVie (ABBV) Get Wolfe Upgrades—Which Pharma Stock Has More Upside?
Wolfe Research upgraded two prominent pharmaceutical companies to Outperform on August 13. The firm upgraded both Biogen Inc. (NASDAQ:BIIB) and AbbVie Inc.
Boeing (BA) and RTX (RTX) Gain From Pentagon Missile Buildup, But Is the Upside Priced In?
On August 14, the Pentagon announced framework agreements with The Boeing Company (NYSE:BA) and RTX Corporation (NYSE:RTX) to increase component production for the SM-3 Block ...
U.S. Steel and Materials Stocks Swing as U.S.-Canada Trade War Escalates With 50% Tariffs
Steel and materials markets fluctuated between rallies and pullbacks as the US-Canada trade relationship shifted from near agreement to open dispute.
Jim Cramer Says “Target’s Doing Better than Walmart Right Now”
Inquiring about Walmart Inc.
Jim Cramer on Arista (ANET) CEO: “She Is Money and the Company’s Fantastic”
During the September 10 episode of Mad Money, a caller inquired about Mad Money host Jim Cramer’s confidence that Arista Networks, Inc.
Jim Cramer Validates Caller’s $1,400 Micron (MU) Thesis, Doubles Down on Charitable Trust Position
On September 10, a caller outlined a detailed financial thesis showing Micron Technology, Inc. (NASDAQ:MU) reaching $1,400 and asked whether the analysis held water.
What American Eagle’s (AEO) Q2 Numbers Say Beyond the Tariff Refund Boost
On September 9, American Eagle Outfitters Inc. (NYSE:AEO) revealed results for its fiscal 2026 second quarter.
United Natural Foods’ (UNFI) Path to Profitability–What Lies Ahead
On September 8, United Natural Foods Inc. (NYSE:UNFI) announced its fourth quarter and full FY26 results.
Imperial Petroleum (IMPP) Posts Robust Q2 Topline Growth Despite Soft Fleet Utilization
On September 10, Imperial Petroleum Inc.
Dell Technologies (DELL) Rallies on Bullish RBC Outlook: Is the Stock a Buy?
On September 11, Dell Technologies Inc.
Lovesac (LOVE) Target Cut by Canaccord, Analysts See 40% Upside
On September 10, Canaccord cut its price target for The Lovesac Company (NASDAQ:LOVE) from $22 to $20 but maintained its Buy rating on the stock.
H&R Block (HRB) Uses AI to Drive Value
Alluvium Asset Management, an asset management company, released its “Conventum – Alluvium Global Fund” second-quarter 2026 investor letter.
Alibaba’s (BABA) Short-Term Capex Drag Creates a 30% Valuation Discount
Alluvium Asset Management, an asset management company, released its “Conventum – Alluvium Global Fund” second-quarter 2026 investor letter.
Zumiez (ZUMZ) Falls on Weak Results and Lower Outlook, But Is the Selloff Overdone?
On September 10, Zumiez Inc.
Why Alluvium Bought Copart (CPRT) Despite the Long-Term Autonomous Driving Risk
Alluvium Asset Management, an asset management company, released its “Conventum – Alluvium Global Fund” second-quarter 2026 investor letter.
Conventum – Alluvium Global Fund’s Q2 2026 Investor Letter
Alluvium Asset Management, an asset management company, released its “Conventum – Alluvium Global Fund” second-quarter 2026 investor letter.
How UnitedHealth (UNH) Leads the AI Revolution in the Insurance Industry
Auxier Asset Management, an investment advisory firm, released its second-quarter 2026 investor letter. The letter can be downloaded here.
Why Kroger Co. (KR) Could Be a Consumer Staples Comeback Story
Auxier Asset Management, an investment advisory firm, released its second-quarter 2026 investor letter. The letter can be downloaded here.
How Caterpillar (CAT) Drives Sector-Leading Performance Beyond AI Models
Auxier Asset Management, an investment advisory firm, released its second-quarter 2026 investor letter. The letter can be downloaded here.
Gates Industrial (GTES) Benefits From AI Growth Without Being an AI Stock
Auxier Asset Management, an investment advisory firm, released its second-quarter 2026 investor letter. The letter can be downloaded here.
Auxier Asset Management’s Q2 2026 Investor Letter
Auxier Asset Management, an investment advisory firm, released its second-quarter 2026 investor letter.
How Allison Transmission Holdings (ALSN) is Capturing New Markets Beyond Commercial Vehicles
Fidelity Investments, an investment management company, recently released its second-quarter 2026 investor letter for the “Fidelity Dividend Growth Fund”.
The Fund’s Largest Relative Detractor: Unowned Advanced Micro Devices (AMD)
Fidelity Investments, an investment management company, recently released its second-quarter 2026 investor letter for the “Fidelity Dividend Growth Fund”.
Seagate Technology (STX): The Primary Beneficiary of the AI Driven HDD Demand
Fidelity Investments, an investment management company, recently released its second-quarter 2026 investor letter for the “Fidelity Dividend Growth Fund”.
Western Digital (WDC): The Fund’s Top Relative Contributor
Fidelity Investments, an investment management company, recently released its second-quarter 2026 investor letter for the “Fidelity Dividend Growth Fund”.
Fidelity Dividend Growth Fund’s Q2 2026 Investor Letter
Fidelity Investments, an investment management company, recently released its second-quarter 2026 investor letter for the “Fidelity Dividend Growth Fund”.
Is First Citizens BancShares (FCNCA) an Undervalued Opportunity?
Broyhill Asset Management, a Charlotte-based firm, issued its second-quarter 2026 investor letter, which is available for download here.
International Trading Institute Expands Professional Trader Development Beyond the Master’s in Trading
Barcelona, Spain, September 15th, 2026, FinanceWire The International Trading Institute (ITI) has expanded its education offering beyond its flagship Master’s in Trading, creating...
Jim Cramer Questions TJX After Marmaxx Stumbles
Jim Cramer raised concerns about The TJX Companies, Inc.
Lilly’s Foundayo Quickly Gains Ground in the Oral Weight-Loss Market
Eli Lilly and Company (NYSE:LLY) says its newly launched oral obesity drug Foundayo has captured more than 30% of new U.S.
Abbott Faces $384 Million Cost as Infant Formula Legal Risks Persist
Abbott Laboratories (NYSE:ABT) has agreed to pay more than $384 million to resolve U.S.
Bank of America Warns of 10%+ Drop in Q3 Investment Banking Fees
Bank of America Corporation (NYSE:BAC) expects third-quarter investment banking fees to fall by at least 10% year over year, which highlights a broader normalization across capital...
BioNTech’s Lung Cancer Drug Shows Signs of a Major Breakthrough
BioNTech SE (NASDAQ:BNTX) reported that its investigational lung-cancer drug gotistobart produced a clinically meaningful overall-survival benefit in the Phase 3 PRESERVE-003 ...
From Novo Nordisk to ‘Novo’: A Strategic Reset Amid Rising Lilly Pressure
Novo Nordisk A/S (NYSE:NVO)'s decision to rebrand its day-to-day identity as “Novo” and launch a cultural reset is primarily a strategic response to the company’s loss of...
Why Rentokil Initial’s (RTO) Discount to Rollins Could Narrow
Broyhill Asset Management, a Charlotte-based firm, issued its second-quarter 2026 investor letter, which is available for download here.
Kimberly-Clark Moves to Clear EU Hurdle with Kenvue Asset Sales
Kimberly-Clark Corporation (NASDAQ:KMB) is preparing asset sales to address EU antitrust concerns surrounding its planned $40 billion acquisition of Kenvue, according to Reuters...
Oracle Adds $700 Million to the Cost of its AI Transformation
Oracle Corporation (NYSE:ORCL) is increasing the expected cost of its fiscal 2026 restructuring plan by about $700 million to roughly $2.8 billion as it simultaneously ramps up...
Nvidia’s Anthropic Investment: Securing AI Demand Amid Rising Competition
On September 13, Reuters reported that Anthropic is in talks to bring NVIDIA Corporation (NASDAQ:NVDA) in as an anchor investor in what could become one of the largest IPOs in...
AstraZeneca’s Oncology Engine Faces a Key Test After Camizestrant Miss
AstraZeneca PLC (NYSE:AZN)'s breast cancer pill Etcamah (camizestrant) failed to meet the primary endpoint in the Phase III SERENA-4 trial, dealing a setback to one of the company...
GSK Cuts 641 Jobs in Vaccine Manufacturing Restructuring
GSK plc (NYSE:GSK) plans to close its vaccine manufacturing facility in Dresden, Germany, by summer 2027, putting 641 jobs at risk.
Colgate-Palmolive Seeks Value Through Portfolio Reshaping
Colgate-Palmolive Company (NYSE:CL) is reportedly exploring the sale of several mass-market personal care brands, including Softsoap, Irish Spring and Speed Stick, in a portfolio...
Strong Volume Growth and Intact Pricing Lifted Masco Corporation (MAS) in Q2
Broyhill Asset Management, a Charlotte-based firm, issued its second-quarter 2026 investor letter, which is available for download here.
Broyhill Maintains Confidence in ServiceNow (NOW). Here’s Why
Broyhill Asset Management, a Charlotte-based firm, issued its second-quarter 2026 investor letter, which is available for download here.
Inside Broyhill’s Bearish Exit of Accenture (ACN)
Broyhill Asset Management, a Charlotte-based firm, issued its second-quarter 2026 investor letter, which is available for download here.
Hedge Fund Resource Center
